For instance, osteosarcoma patients who have a high BMI at diagnosis have a lower overall survival compared with patients who have a normal BMI [22], which is consistent with our hypothesized role of PLA2G16 in promoting tumor progression and poor prognosis by mediating lung metastases. Here, PLAAT3 is linked to osteosarcoma.